AI-Driven Discovery
Reshaping Biomedical Frontiers

Empowering Breakthroughs in Personalized Medicine
through our AI powered Drug Discovery platform MolculeGEN.

AI-Driven Discovery Reshaping Biomedical Frontiers By Knowdis
How We're Harnessing AI to Transform Drug Discovery
Antibody Design By Moleculeai

Antibody Design

Drug design remains a challenging endeavor due to the complexity of the involved design space. Artificial Intelligence provides a unique shot at the problem due to its capability of enabling efficient horizon exploration.

We are applying our AI capabilities in screening and de novo generation of antibodies and small molecule drugs against challenging targets such as intrinsically disordered pathogenic proteoforms involved in Parkinson’s disease.

Multidisciplinary Expertise

Our team consists of an ideal mix of members having strong experience in both the fields of biophysics and AI. We strongly believe in the importance of a multidisciplinary team for tackling the problem.

Multidisciplinary Expertise By Moleculeai
Biophysics Meets Deep Learning

Biophysics Meets Deep Learning

Deep Learning has revolutionized many fields but still remains in the nascent stages for drug design. Models like AlphaFold provide a strong foundation for the field but end-to-end solutions need to go far beyond. Hence, we develop novel architectures, built using biophysics principles at the core.

Molecule GEN

Platform by Molecule AI

Try Molecule GEN

One of a kind integrated drug discovery platform

De novo target aware molecule generation (hit-generation)

Hit to lead and lead optimization capabilities


Featured in News

See All News